- Home
- RADX vs RMTI Comparison
RADX vs RMTI Comparison
Compare RADX & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RADX
- RMTI
- Stock Information
- Founded
- RADX 2021
- RMTI 1994
- Country
- RADX Australia
- RMTI United States
- Employees
- RADX N/A
- RMTI N/A
- Industry
- RADX
- RMTI Biotechnology: Pharmaceutical Preparations
- Sector
- RADX
- RMTI Health Care
- Exchange
- RADX NYSE
- RMTI Nasdaq
- Market Cap
- RADX 32.5M
- RMTI 33.0M
- IPO Year
- RADX N/A
- RMTI 1998
- Fundamental
- Price
- RADX $4.60
- RMTI $0.91
- Analyst Decision
- RADX Strong Buy
- RMTI Strong Buy
- Analyst Count
- RADX 2
- RMTI 2
- Target Price
- RADX $13.50
- RMTI $4.00
- AVG Volume (30 Days)
- RADX 22.6K
- RMTI 163.6K
- Earning Date
- RADX 02-26-2025
- RMTI 08-07-2025
- Dividend Yield
- RADX N/A
- RMTI N/A
- EPS Growth
- RADX N/A
- RMTI N/A
- EPS
- RADX N/A
- RMTI N/A
- Revenue
- RADX $204,609.00
- RMTI $97,727,000.00
- Revenue This Year
- RADX N/A
- RMTI N/A
- Revenue Next Year
- RADX N/A
- RMTI $11.16
- P/E Ratio
- RADX N/A
- RMTI N/A
- Revenue Growth
- RADX N/A
- RMTI 12.82
- 52 Week Low
- RADX $3.50
- RMTI $0.86
- 52 Week High
- RADX $50.82
- RMTI $5.15
- Technical
- Relative Strength Index (RSI)
- RADX N/A
- RMTI 39.80
- Support Level
- RADX N/A
- RMTI $0.91
- Resistance Level
- RADX N/A
- RMTI $1.00
- Average True Range (ATR)
- RADX 0.00
- RMTI 0.05
- MACD
- RADX 0.00
- RMTI -0.00
- Stochastic Oscillator
- RADX 0.00
- RMTI 11.71
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.